TABLE 3.
Comparison of C. pneumoniae IgG seropositivities between patients and controls using different EIAs
| Patient typea | Test | No. of positive patients/total (%) | No. of positive controls/total (%) | P value |
|---|---|---|---|---|
| A | MIF | 88/106 (83.0) | 88/112 (78.6) | 0.405 |
| MCp sELISA | 94/106 (88.7) | 90/112 (80.4) | 0.091 | |
| MC rELISA | 65/106 (61.3) | 54/112 (48.2) | 0.052 | |
| LS EIA | 75/90 (83.3) | 71/112 (63.4) | 0.002 | |
| B | MIF | 81/98 (82.7) | 88/112 (78.6) | 0.457 |
| MCp sELISA | 87/98 (88.8) | 90/112 (80.4) | 0.094 | |
| MC rELISA | 60/98 (61.2) | 54/112 (48.2) | 0.059 | |
| LS EIA | 68/82 (82.9) | 71/112 (63.4) | 0.003 | |
| C | MIF | 74/89 (83.1) | 88/112 (78.6) | 0.415 |
| MCp sELISA | 79/89 (88.8) | 90/112 (80.4) | 0.106 | |
| MC rELISA | 53/89 (59.6) | 54/112 (48.2) | 0.110 | |
| LS EIA | 61/73 (83.6) | 71/112 (63.4) | 0.003 | |
| D | MIF | 54/62 (87.1) | 88/112 (78.6) | 0.164 |
| MCp sELISA | 57/62 (91.9) | 90/112 (80.4) | 0.043 | |
| MC rELISA | 38/62 (61.3) | 54/112 (48.2) | 0.098 | |
| LS EIA | 46/50 (92.0) | 71/112 (63.4) | 0.0001 | |
| E | MIF | 7/9 (77.8) | 88/112 (78.6) | 0.956 |
| MCp sELISA | 8/9 (88.9) | 90/112 (80.4) | 0.530 | |
| MC rELISA | 7/9 (77.8) | 54/112 (48.2) | 0.088 | |
| LS EIA | 7/9 (77.8) | 71/112 (63.4) | 0.386 | |
| F | MIF | 20/27 (74.1) | 88/112 (78.6) | 0.614 |
| MCp sELISA | 22/27 (81.5) | 90/112 (80.4) | 0.895 | |
| MC rELISA | 15/27 (55.6) | 54/112 (48.2) | 0.493 | |
| LS EIA | 15/23 (65.2) | 71/112 (63.4) | 0.868 | |
| G | MIF | 31/35 (88.6) | 88/112 (78.6) | 0.188 |
| MCp sELISA | 32/35 (91.4) | 90/112 (80.4) | 0.128 | |
| MC rELISA | 24/35 (68.6) | 54/112 (48.2) | 0.035 | |
| LS EIA | 25/27 (92.6) | 71/112 (63.4) | 0.003 | |
| H | MIF | 23/27 (85.2) | 88/112 (78.6) | 0.442 |
| MCp sELISA | 25/27 (92.6) | 90/112 (80.4) | 0.131 | |
| MC rELISA | 14/27 (51.9) | 54/112 (48.2) | 0.734 | |
| LS EIA | 21/23 (91.3) | 71/112 (63.4) | 0.009 |
A, patients with either angiographically defined normal coronary arteries, coronary atherosclerosis with 50% stenosis, one-vessel disease, two-vessel disease, or three-vessel disease; B, patients with either angiographically defined coronary atherosclerosis with <50% stenosis, one-vessel disease, two-vessel disease, or three-vessel disease; C, patients with either angiographically defined one-vessel disease, two-vessel disease, or three-vessel disease; D, patients with angiographically defined two- or three-vessel disease; E, patients with angiographically defined coronary atherosclerosis with <50% stenosis; F, patients with angiographically defined one-vessel disease; G, patients with angiographically defined two-vessel disease; H, patients with angiographically defined three-vessel disease.